Yeah PESI EBITA was a bit lighter than I was expecting. But the $85M revenue figure was WAY above was I was looking for. We know Q1 will be a loss. So earning .30+/share over the next 3 quarters wouldn't be bad. I'll be adding a few more next week. The catalyst to a much higher share price is still the medical division. We should get an update on that next month. And then hopefully some positive news over the summer and later this year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.